Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Grazoprevir and Elbasvir for HCV GT1 and GT6 With or Without HIV
NCT03037151Phase 4Unknown
- Sponsor
- HIV-NAT
- Start
- Aug 2018
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of grazoprevir, elbasvir in hepatitis C (HCV), sponsored by HIV-NAT. Status: unknown.
02
Drugs
grazoprevirelbasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT03037151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03037151.